$SINT
Sintx Technologies, Inc. Stock $sint

$sint Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000162828015003972 Filed on May 08, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q4
Revenue	$4.780M	$4.743M	$5.150M
YoY Change	-18.09%	-17.94%	-9.81%
Cost Of Revenue	$1.363M	$1.522M	$2.720M
YoY Change	-14.97%	-7.7%	78.95%
Gross Profit	$3.417M	$3.221M	$2.430M
YoY Change	-19.28%	-22.03%	-42.0%
Gross Profit Margin	71.49%	67.91%	47.18%
Selling, General & Admin	$4.460M	$5.384M	$5.140M
YoY Change	-62.27%	-29.12%	-13.61%
% of Gross Profit	130.52%	167.15%	211.52%
Research & Development	$1.553M	$1.843M	$1.140M
YoY Change	-48.93%	211.84%	93.22%
% of Gross Profit	45.45%	57.22%	46.91%
Depreciation & Amortization	$530.0K	$428.0K	$590.0K
YoY Change	-10.17%	-1.15%	9.26%
% of Gross Profit	15.51%	13.29%	24.28%
Operating Expenses	$6.013M	$7.227M	$6.280M
YoY Change	-59.54%	-11.73%	-4.12%
Operating Profit	-$2.596M	-$4.006M	-$3.850M
YoY Change	-75.57%	-1.23%	63.14%
Interest Expense	$1.134M	$1.100M	-$3.030M
YoY Change	104.69%	107.55%	-183.7%
% of Operating Profit
Other Income/Expense, Net	-$3.337M	-$1.375M	-$2.220M
YoY Change	27.81%	109.28%	2366.67%
Pretax Income	-$5.933M	-$5.381M	-$9.700M
YoY Change	-55.19%	14.17%	-1569.7%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.930M	-$5.381M	-$9.700M
YoY Change	-55.21%	14.17%	-1569.7%
Net Earnings / Revenue	-124.06%	-113.45%	-188.35%
Basic Earnings Per Share
Diluted Earnings Per Share	-$593.0M	-$1.079B	-$2.941B
COMMON SHARES
Basic Shares Outstanding	55.37M shares	26.76M
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.39M	$14.88M	$18.25M
YoY Change	7.27%	12.22%	700.66%
Cash & Equivalents	$12.39M	$14.88M	$18.25M
Short-Term Investments			$0.00
Other Short-Term Assets	$1.310M	$1.460M	$1.250M
YoY Change	-10.27%	-27.36%	-73.63%
Inventory	$10.61M	$11.20M	$11.68M
Prepaid Expenses
Receivables	$2.509M	$2.568M	$2.513M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$26.83M	$30.11M	$33.68M
YoY Change	-6.68%	2.2%	69.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.009M	$3.286M	$3.515M
YoY Change	-23.8%	-9.33%	-0.45%
Goodwill	$6.163M	$6.163M	$6.163M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$3.938M	$4.063M	$4.188M
YoY Change	-11.27%	-10.96%	-10.67%
Long-Term Investments
YoY Change
Other Assets	$35.00K	$35.00K	$35.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$13.15M	$13.55M	$13.90M
YoY Change	-9.87%	-5.83%	-3.58%
TOTAL ASSETS
Total Short-Term Assets	$26.83M	$30.11M	$33.68M
Total Long-Term Assets	$13.15M	$13.55M	$13.90M
Total Assets	$39.97M	$43.66M	$47.58M
YoY Change	-7.75%	-0.43%	38.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$831.0K	$1.217M	$778.0K
YoY Change	-67.84%	-46.51%	-76.96%
Accrued Expenses	$3.193M	$3.117M	$3.146M
YoY Change	34.95%	-21.37%	-15.23%
Deferred Revenue
YoY Change
Short-Term Debt	$19.77M	$19.16M	$19.07M
YoY Change	4.6%	18.78%	6.36%
Long-Term Debt Due	$19.77M	$19.16M	$19.07M
YoY Change	4.58%	18.75%	6.39%
Total Short-Term Liabilities	$23.79M	$23.49M	$22.99M
YoY Change	-0.25%	5.01%	-8.07%
LONG-TERM LIABILITIES
Long-Term Debt	$2.779M	$3.110M	$3.061M
YoY Change	128.54%
Other Long-Term Liabilities	$177.0K	$134.0K	$134.0K
YoY Change	-94.79%	0.0%	0.0%
Total Long-Term Liabilities	$2.956M	$3.244M	$3.195M
YoY Change	143.09%	2320.9%	2284.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.79M	$23.49M	$22.99M
Total Long-Term Liabilities	$2.956M	$3.244M	$3.195M
Total Liabilities	$26.75M	$26.74M	$26.19M
YoY Change	6.7%	18.8%	4.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$183.9M	-$177.9M	-$172.5M
YoY Change		22.99%	23.29%
Common Stock	$658.0K	$291.0K	$179.4M
YoY Change		134.68%	-1465.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$120.0K	$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.160M	$3.180M	$6.910M
YoY Change
Total Liabilities & Shareholders Equity	$39.97M	$43.66M	$47.58M
YoY Change	-7.75%	-0.43%	38.62%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q4
OPERATING ACTIVITIES
Net Income	-$5.930M	-$5.381M	-$9.700M
YoY Change	-55.21%	14.17%	-1569.7%
Depreciation, Depletion And Amortization	$530.0K	$428.0K	$590.0K
YoY Change	-10.17%	-1.15%	9.26%
Cash From Operating Activities	-$2.350M	-$2.970M	-$3.090M
YoY Change	-63.34%	48.5%	-30.72%
INVESTING ACTIVITIES
Capital Expenditures	-$140.0K	$277.0K	-$140.0K
YoY Change	-82.93%	-49.45%	-81.58%
Acquisitions
YoY Change
Other Investing Activities	$10.00K	$0.00	$20.00K
YoY Change	-97.78%	-100.0%	-140.0%
Cash From Investing Activities	-$140.0K	-$270.0K	-$130.0K
YoY Change	-62.16%	-54.24%	-84.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$120.0K
YoY Change		-100.78%
Debt Paid & Issued, Net		$0.00
YoY Change		-100.0%
Cash From Financing Activities	0.000	-120.0K	11.11M
YoY Change	-100.0%	-100.88%
NET CHANGE
Cash From Operating Activities	-2.350M	-2.970M	-3.090M
Cash From Investing Activities	-140.0K	-270.0K	-130.0K
Cash From Financing Activities	0.000	-120.0K	11.11M
Net Change In Cash	-2.490M	-3.360M	7.890M
YoY Change	44.77%	-130.6%	-249.43%
FREE CASH FLOW
Cash From Operating Activities	-$2.350M	-$2.970M	-$3.090M
Capital Expenditures	-$140.0K	$277.0K	-$140.0K
Free Cash Flow	-$2.210M	-$3.247M	-$2.950M
YoY Change	-60.47%	27.43%	-20.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	amda	Accrued Final Loan Payment Fees Current AccruedFinalLoanPaymentFeesCurrent	233000	USD
CY2015Q1	amda	Accrued Final Loan Payment Fees Current AccruedFinalLoanPaymentFeesCurrent	353000	USD
CY2015Q1	amda	Classof Warrant Noncash Exercise Provision Threshold ClassofWarrantNoncashExerciseProvisionThreshold	P120D
CY2014Q4	amda	Debt Instrument Face Amount Current DebtInstrumentFaceAmountCurrent	20000000	USD
CY2015Q1	amda	Debt Instrument Face Amount Current DebtInstrumentFaceAmountCurrent	20000000	USD
CY2014Q4	amda	Debt Instrument Face Amount Noncurrent DebtInstrumentFaceAmountNoncurrent	4500000	USD
CY2015Q1	amda	Debt Instrument Face Amount Noncurrent DebtInstrumentFaceAmountNoncurrent	4298000	USD
CY2014Q4	amda	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	930000	USD
CY2015Q1	amda	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	843000	USD
CY2014Q4	amda	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	1439000	USD
CY2015Q1	amda	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	1188000	USD
CY2014Q1	amda	Gains Losseson Extinguishmentof Derivative Instruments GainsLossesonExtinguishmentofDerivativeInstruments	0	USD
CY2015Q1	amda	Gains Losseson Extinguishmentof Derivative Instruments GainsLossesonExtinguishmentofDerivativeInstruments	-16000	USD
CY2014Q1	amda	Provision For Inventory Reserve ProvisionForInventoryReserve	415000	USD
CY2015Q1	amda	Provision For Inventory Reserve ProvisionForInventoryReserve	326000	USD
CY2014Q1	amda	Reclassification Of Warrant Liability ReclassificationOfWarrantLiability	5000	USD
CY2015Q1	amda	Reclassification Of Warrant Liability ReclassificationOfWarrantLiability	0	USD
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001269026
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55371597	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	AMEDICA Corp
CY2015Q1	dei	Trading Symbol TradingSymbol	AMDA
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	778000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1217000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2513000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2568000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3146000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3117000	USD
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	531000	USD
CY2015Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	508000	USD
CY2014Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	846000	USD
CY2015Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	770000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	179148000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	180896000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1404000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	660000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	60000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	209000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	551000	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	125000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	125000	USD
CY2014Q1	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	2000	USD
CY2015Q1	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	5000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2800000	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43300000	shares
CY2014Q4	us-gaap	Assets Assets	47583000	USD
CY2015Q1	us-gaap	Assets Assets	43658000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	33682000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	30111000	USD
CY2014Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	0	USD
CY2015Q1	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	0	USD
CY2015Q1	us-gaap	Cash Cash	14900000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2279000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13257000	USD
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26353666	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29092095	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14882000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18247000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10978000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3365000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26353666	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29092095	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	264000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	291000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	1649000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	1522000	USD
CY2014Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	24500000	USD
CY2015Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	24298000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2369000	USD
CY2015Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2031000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	57000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	62000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	517000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	497000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	433000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	428000	USD
CY2014Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-114000	USD
CY2015Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-177000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	13970000	USD
CY2015Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	13245000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.79
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1001000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	923000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5399000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5524000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1300000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	375000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	501000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	501000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	501000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	501000	USD
CY2014Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3000	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4713000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	6163000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	6163000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5381000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	4131000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	3221000	USD
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-79000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3075000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2027000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-915000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	200000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-268000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1958000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-293000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2610000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	330000	USD
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	42000	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	9587000	USD
CY2015Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	9587000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4188000	USD
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4063000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	530000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	1100000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	238000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	548000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	333000	USD
CY2015Q1	us-gaap	Interest Payable Current InterestPayableCurrent	398000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10350000	USD
CY2015Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9946000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	11675000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	11197000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	839000	USD
CY2015Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	950000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	486000	USD
CY2015Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	301000	USD
CY2014Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
CY2015Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47583000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43658000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22994000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	23491000	USD
CY2015Q1	us-gaap	Liquidity Disclosure Sufficient Cash And Waivers Note LiquidityDisclosureSufficientCashAndWaiversNote	As discussed further in Note 7, the Company has entered into a term loan with Hercules Technology Growth Capital, Inc. (“Hercules Technology”), as administrative and collateral agent for the lenders thereunder and as lender, and Hercules Technology III, LP, as lender (the “Hercules Term Loan”). The Hercules Term Loan has a liquidity covenant that requires the Company to maintain a cash balance of not less than $9.0 million.
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	22131000	USD
CY2015Q1	us-gaap	Long Term Debt LongTermDebt	22267000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	19070000	USD
CY2015Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	19157000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3061000	USD
CY2015Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3110000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	13569000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-120000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-590000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-274000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2001000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2971000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-4713000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-5381000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-657000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1375000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	8187000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	7227000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4056000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4006000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145000	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	103000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35000	USD
CY2014Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3000000	USD
CY2015Q1	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3100000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	134000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	134000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	USD
CY2014Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2015Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	120000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	548000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	277000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1247000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1464000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15369000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3515000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3286000	USD
CY2014Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-17000	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-20000	USD
CY2014Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1800000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	591000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1843000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-172505000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-177886000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	5780000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	4743000	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4521000	USD
CY2015Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3357000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1404000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	592000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0278
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.45
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	663504	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.21
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	151358	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	889822	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1485759	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1383479	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1828058	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.92
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1765941	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.98
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.06
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.06
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.95
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2015Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	206380	shares
CY2014Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2015Q1	us-gaap	Stock Issued1 StockIssued1	739000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	30000	shares
CY2015Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	617447	shares
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6907000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3181000	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	120000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5967400	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26929447	shares
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. Some of the more significant estimates relate to inventory, allowance for accounts receivable, stock-based compensation, long-lived and intangible assets and derivative liabilities. </font></div></div>

Files In Submission

Name	View Source	Status
0001628280-15-003972-index-headers.html	Edgar Link	pending
0001628280-15-003972-index.html	Edgar Link	pending
0001628280-15-003972.txt	Edgar Link	pending
0001628280-15-003972-xbrl.zip	Edgar Link	pending
amda-20150331.xml	Edgar Link	completed
amda-20150331.xsd	Edgar Link	pending
amda-20150331_cal.xml	Edgar Link	unprocessable
amda-20150331_def.xml	Edgar Link	unprocessable
amda-20150331_lab.xml	Edgar Link	unprocessable
amda-20150331_pre.xml	Edgar Link	unprocessable
amda2014331ex311.htm	Edgar Link	pending
amda2015033110q.htm	Edgar Link	pending
amda2015331ex312.htm	Edgar Link	pending
amda2015331ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SINT
Sintx Technologies, Inc. Stock $sint

2015 Q2 Form 10-Q Financial Statement

#000162828015003972 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT Sintx Technologies, Inc. Stock $sint

2015 Q2 Form 10-Q Financial Statement

#000162828015003972 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT
Sintx Technologies, Inc. Stock $sint